ClinicalTrials.gg
Status unknownNCT03376113Updated Dec 18, 2017

The Effect of a Brief Psychological Intervention on Reducing Self-harm Repetition: Feasibility Study

An interventional study of the volitional help sheet in Suicide and Self-harm, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2017-12-18.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 10 studies in Suicide with a site in Taiwan — none open to participants now, none under way, none of them phase 3. Suicide · Taiwan.

Started
2017
the only one that year
No phase
6 of 10
none open now
Registered
7th of 10
by date
Lead sponsor
2 of 10
National Taiwan University Hospital

Among the 10 studies in Suicide with a site in Taiwan, this one is the only one that started in 2017, is one of 6 with no phase, and was the 7th registered.

By phase

10 studies; the count open now beside each. This study's row is marked.

No phasethis study6 · 0 open
Observational2 · 0 open
Phase 11 · 0 open
Phase 21 · 0 open

By the year they started

First in 2006; this study’s year is marked. 1 started in 2017.

What they test

Size and results

Median enrollment 58 across the 8 interventional studies, 75 across the 2 observational. Of the 8 that completed or were terminated, 1 (13%) have results posted.

Was this useful?
Download CSVWith an account: the 10 studies in Suicide with a site in Taiwan as a file.
02

Study summary

Recent research has focused on examining brief interventions for reducing self-harm, such as the volitional help sheet (VHS). The VHS is a theory-based psychological intervention. Two previous studies applying this tool for reducing self-harm repetition showed inconsistent results; one showed reduced subsequent self-reported suicidal ideation and behavior in patients presenting to hospital for self-harm, whilst the other showed no effect on the number of patients who re-presented to hospital with self-harm. The aim of this study is to investigate the feasibility of the VHS intervention amongst self-harm patients in Taiwan and explore its effect on self-harm repetition based on self-reported self-harm, hospital re-presentations with self-harm, and self-harm episodes from a nationwide self-harm registry. It is a two-phase study: first a qualitative study and second an exploratory randomized control trial. The first study is to interview people who self-harm about their perceptions about the VHS on the online platform, to inform the modification of VHS and the best way to intervene. The second is to examine the feasibility and effect of this intervention at the emergency department setting.

Read the detailed description

Suicide is an important public health issue and leads to substantial social and economic burden. Self-harm is a significant risk factor of subsequent suicide attempt and suicide. However, previously studied interventions for reducing self-harm repetition such as long-term psychological therapies would not be feasible at acute settings such as emergency departments. It is also challenging to maintain patients who self-harm in long-term treatments. The volitional help sheet (VHS) is a brief, theory-based psychological intervention. Two recent studies applying this tool for reducing self-harm repetition showed inconsistent results; one showed reduced subsequent self-reported suicidal ideation and behavior in patients presenting to hospital for self-harm, whilst the other showed no effect on the number of patients who re-presented to hospital with self-harm. To investigate the feasibility of the VHS intervention for self-harm patients and explore its effect on self-harm repetition in Taiwan, the investigators will conduct a two-phase study: first a qualitative study and second an exploratory randomized control trial.

In phase I, the qualitative study, eight patients with recent self-harm will be recruited from the psychiatric ward and interviewed about their perceptions about the VHS and views about the best way to intervene.

In phase II, the exploratory randomized control trial, the investigators will recruit 60 patients presenting to the emergency department following an episode of self-harm. Patients will be randomly assigned (1:1) to the intervention group, which will be given the VHS intervention on an online platform, or the control group to examine the feasibility and effect of this intervention. The primary outcomes will be self-harm repetition based on: i) self-reported self-harm in a telephone based follow-up survey, ii) hospital re-presentations with self-harm based on hospital records, and iii) self-harm episodes from a nationwide self-harm registry, the National Suicide Surveillance System (NSSS). The NSSS includes a web-based reporting system and all emergency departments across the country are asked to report information about all people present to hospitals following an episode of self-harm. In addition, we will report the sub-group analyses for past self-harm hospitalisation according to the suggestion from the study testing VHS on reducing self-harm in United Kingdom.

03

Conditions studied

  • Suicide and Self-harm

Keywords

  • self-harm
  • psychological intervention
04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

In phase I

Inclusion Criteria:

  1. With self-harm experience in the past month
  2. Aged 20 years or over

Exclusion Criteria:

  1. With severe hallucinations or delusions or medically unfit for interview
  2. Limited hands movement (e.g. seriously wounded wrists)

In phase II

Inclusion Criteria:

  1. Admitted to the ER following an episode of self-harm
  2. Aged 20 years or over

Exclusion Criteria:

  1. With severe hallucinations or delusions or medically unfit for interview
  2. Limited hands movement (e.g. seriously wounded wrists)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    VHS group

    Patients will be asked to make links between critical situations and appropriate solutions in the volitional help sheet (VHS).

    Behavioral: the volitional help sheet

  • No intervention
    Control group

    Patients will be asked to read the VHS. This is an active control group. That means all patients in this study will be exposed to situations and solutions in the VHS.

Interventions

  • Behavioralthe volitional help sheet

    A sheet includes two columns: one shows critical situations that easily trigger self-harm; other one shows appropriate solutions for patients to prevent self-harm.

06

What researchers measure

Primary outcomes

  1. The acceptability of the intervention to patients

    The investigators will conduct face-to-face qualitative interviews to understand the acceptability of the intervention amongst patients.

    Time frame: within 6 months of study completion

  2. The feasibility of intervention delivery at the ER setting

    The investigators will conduct face-to-face qualitative interviews to understand the feasibility of intervention delivery at the ER setting.

    Time frame: within 6 months of study completion

  3. Patient recruitment

    Recruitment: the proportion of patients who are eligible and invited actually consent to participate.

    Time frame: Baseline

  4. The proportion of participating patients who can be reached by telephone contact at the 3-month follow-up.

    The proportion of participating patients who can be reached by telephone contact at the 3-month follow-up.

    Time frame: 3 months

  5. The proportion of participating patients who can be reached by telephone contact at the 6-month follow-up.

    The proportion of participating patients who can be reached by telephone contact at the 6-month follow-up.

    Time frame: 6 months

  6. The proportion of participating patients who can be traced from the hospital record at the 3-month.

    The proportion of participating patients who can be traced from the hospital record at the 3-month.

    Time frame: 3 months

  7. The proportion of participating patients who can be traced from the hospital record at the 6-month.

    The proportion of participating patients who can be traced from the hospital record at the 6-month.

    Time frame: 6 months

  8. The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 6-month.

    The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 6-month.

    Time frame: 6 months

  9. The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 3-month.

    The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 3-month.

    Time frame: 3 months

  10. Change in scores on a self-report suicidal behaviors assessment from baseline to 3 months

    As measured by the total score of the Suicidal Behaviors Questionnaire-Revised (SBQ-R), a 4-item scale for assessing suicidal behavior and ideation. The total score ranges from 3 to 18.

    Time frame: Baseline, 3 months

  11. Change in scores on a self-report suicidal behaviors assessment from baseline to 6 months

    As measured by the total score of the Suicidal Behaviors Questionnaire-Revised (SBQ-R), a 4-item scale for assessing suicidal behavior and ideation. The total score ranges from 3 to 18.

    Time frame: Baseline, 6 months

  12. Number of repeat self-harm episodes per person in 3 months after intervention based on hospital records

    Number of repeat self-harm episodes per person in 3 months after intervention based on hospital records

    Time frame: 3 months

  13. Number of repeat self-harm episodes per person in 3 months after intervention recorded in the nationwide self-harm registry

    Number of repeat self-harm episodes per person in 3 months after intervention recorded in the nationwide self-harm registry

    Time frame: 3 months

  14. Number of repeat self-harm episodes per person in 6 months after intervention based on hospital records

    Number of repeat self-harm episodes per person in 6 months after intervention based on hospital records

    Time frame: 6 months

  15. Number of repeat self-harm episodes per person in 6 months after intervention recorded in the nationwide self-harm registry

    Number of repeat self-harm episodes per person in 6 months after intervention recorded in the nationwide self-harm registry

    Time frame: 6 months

  16. Time to next self-harm repetition (in days) following randomization

    Time to next self-harm repetition (in days) following randomization according to hospital records and a nationwide self-harm registry.

    Time frame: 6 months

Secondary outcomes

  1. Times of use of the volitional help sheet

    Times of use of the volitional help sheet based on the number of visits to the individualized website of the volitional help sheet.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
    Recruiting
08

References and documents

Publications

  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2. PubMed 33884617 ↗
  • Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2. PubMed 32368793 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2017 (actual). Primary completion is estimated for Oct 2019, 23 months after the start.

Of 308 non-industry interventional studies with no phase under Suicide, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 54. This study's planned 23 months is below that.

Counting every sponsor, half of 319 studies reached it within 30 months; a quarter within 15 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2017
First posted
Dec 18, 2017
StartActual
Nov 3, 2017
Primary completionEst.
Oct 2019
CompletionEst.
Oct 2019
Last update
Dec 18, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03376113
Collaborators
Academia Sinica, Taiwan
Responsible party
Sponsor
First posted
Dec 18, 2017
Start date
Nov 3, 2017
Primary completion
Oct 2019 (estimated)
Completion
Oct 2019 (estimated)
Last update
Dec 18, 2017

Study contacts

Shu-Sen Chang, MD, MSc, PhD
Contact
shusenchang@ntu.edu.tw
+886 2 33668062
Shu-Sen Chang, MD, MSc, PhD
principal investigator · National Taiwan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion